Status:
COMPLETED
Effect of Attention Training or SSRIs on Symptoms and Neural Activation in Social Anxiety
Lead Sponsor:
Tel Aviv University
Collaborating Sponsors:
Sheba Medical Center
Tel-Aviv Sourasky Medical Center
Conditions:
Social Anxiety Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the clinical efficacy and neuro-cognitive mechanisms of Gaze-Contingent Usic Reward Therapy for social anxiety disorder, compared with treatment with SSRIs or...
Detailed Description
Attention biases in threat processing have been assigned a prominent role in the etiology and maintenance of anxiety disorders. The purpose of this study is to determine whether giving gaze-contingent...
Eligibility Criteria
Inclusion
- A signed consent form
- Men and women between the ages of 18 and 65.
- Meeting a current diagnosis of Social Anxiety Disorder (SP) according to the DSM-IV.
- SP as the primary diagnosis: In cases of co-morbidity, SP will be deemed as the most distressing and clinically significant condition among the co-morbid disorders.
- No current pharmaco-therapy.
Exclusion
- A diagnosis of psychotic or bipolar disorders.
- A diagnosis of a neurological disorder (i.e., epilepsy, brain injury).
- Drug or alcohol abuse.
- Any current pharmacological treatment.
- Any current psychotherapeutic treatment.
- Change in treatment during the study.
- Poor judgment capacity (i.e., children under 18 and special populations).
Key Trial Info
Start Date :
July 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03346239
Start Date
July 20 2018
End Date
December 1 2021
Last Update
February 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv University
Tel Aviv, Israel